TrialThe Lancet. Infectious diseases2025

Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial.

Rodney Dawson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.